Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway.
Li J, Peng J, Zhao S, Zhong Y, Wang Y, Hu J, Zhang C, Cheng M, Xia G, Hu Y, Huang K, Wang Y, Liang M.
Li J, et al. Among authors: wang y.
Front Pharmacol. 2019 Jul 5;10:764. doi: 10.3389/fphar.2019.00764. eCollection 2019.
Front Pharmacol. 2019.
PMID: 31333473
Free PMC article.